Q2 2025 IHH Healthcare Bhd Earnings Call Transcript
Key Points
- IHH Healthcare Bhd (XKLS:5225) achieved a 7% growth in revenue and a 2% growth in EBITDA despite challenging macroeconomic conditions.
- The company declared an interim dividend of MYR 0.05, up from MYR 0.045 last year, indicating strong financial health.
- Mount Elizabeth Orchard's renovation was completed on schedule, with phased reopening expected to contribute positively in the coming quarters.
- The company received the highest AAA rating from two top Malaysian rating agencies, which will help manage financing costs better.
- IHH Healthcare Bhd's diversified platform across multiple geographies ensures resilience and risk mitigation, with robust growth on a constant currency basis.
- The company faces payer pressure in both Malaysia and Singapore, which could impact margins.
- Currency translation losses due to the strengthening ringgit have offset some of the company's growth.
- The Mount Elizabeth Orchard facility is currently operating at half capacity, affecting immediate revenue potential.
- There is a structural shift towards day care, which may require adjustments in CapEx and operational strategies.
- Foreign patient contribution in Turkey declined due to a faster increase in local patient revenue and currency depreciation.
Ladies and gentlemen, good evening, and welcome to the second quarter and first-half 2025 financial results of IHH Healthcare's Analyst Briefing Conference Call. (Operator Instructions) I must advise you that this conference is being recorded today on August 29, 2025.
I would now like to hand the conference over to your first speaker today, Mr. Kelvin Chong, from Investor Relations at IHH. Please go ahead, Mr. Chong.
Thank you, operator. Good evening, everyone, and welcome to our analyst briefing for Q2 '25. Thank you for taking time on Friday to join us. My name is Kelvin, I'm from the IR team.
Together with me today is Dr. Prem, our Group CEO; and Mr. Dilip Kadambi, our Group CFO. A warm welcome to all.
Dr. Prem will kick this off by giving a high-level overview as well as opening remarks for the quarter, followed by Dilip who will take us through the high-level financial highlights for Q2 FY25. We will then cover some key operational updates
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
